BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND CEACAM5, CEA AND Diagnosis
213 results:

  • 1. [Ultrasonographic features of thyroid carcinoma of different sizes: comparison between medullary thyroid carcinomas and papillary thyroid carcinomas].
    Zhang D; Yang F; Wang Y; Mu JL; Wei XQ; Wei X
    Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):133-139. PubMed ID: 38418187
    [No Abstract]    [Full Text] [Related]  

  • 2. sPD-L1 and sPD-L2 in plasma of patients with lung cancer and their clinical significance.
    Han S; Zhang Y; Yuan J; Wu Y; Zhou Y; Zhou Y; Li X; Zhou S
    Cytokine; 2024 Apr; 176():156532. PubMed ID: 38330638
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exploring the application value of pro-gastrin-releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma.
    Miao Q; Lv X; Luo L; Zhang J; Cai B
    Cancer Med; 2023 Oct; 12(19):19576-19582. PubMed ID: 37754747
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
    Deandrea M; Piticchio T; Mormile A; Retta F; Canale G; Caracciolo A; Daniele L; Trimboli P
    Endocr J; 2023 Nov; 70(11):1061-1067. PubMed ID: 37690841
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
    Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
    BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. thyroid hormones as biomarkers of lung cancer: a retrospective study.
    Ma Z; Song P; Ji D; Zheng M; Qiu G; Liu Z; Wang B
    Ann Med; 2023 Dec; 55(1):2196088. PubMed ID: 37014291
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Value of Baseline Calcitonin for Differential diagnosis of Medullary thyroid cancer].
    Liu QH; Nie X; He Y; Yin MT; Li GX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):432-438. PubMed ID: 36949711
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Hereditary medullary thyroid cancer].
    Fendrich V; Zahn A
    Chirurgie (Heidelb); 2023 May; 94(5):393-399. PubMed ID: 36799965
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Clinicopathological analysis of superior mediastinal lymph node metastases in medullary thyroid carcinoma].
    He YY; Chen YT; Wang J; Chen MQ; Zhu YM; Ni S; Liu SY
    Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):82-87. PubMed ID: 36709124
    [No Abstract]    [Full Text] [Related]  

  • 10. Refined diagnosis of Pleural Effusions by Immunocytochemistry of Cell Blocks.
    Koyi H; Wilander E
    Anticancer Res; 2023 Feb; 43(2):669-673. PubMed ID: 36697096
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Other markers of medullary thyroid cancer, not only calcitonin.
    Censi S; Manso J; Mian C
    Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A Rare Case of Negative Serum Calcitonin in Metastatic Medullary thyroid Carcinoma: diagnosis, Treatment, and Follow-Up Strategy.
    Licata L; Di Fidio CA; Vacante M; Basile F; Biondi A; Richiusa P; Gurrera A; Ciuni R
    Am J Case Rep; 2022 Sep; 23():e935207. PubMed ID: 36088532
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Melanotic medullary thyroid carcinoma: A case report with review of the literature.
    Brzezinska KA; Bhardwaj S; Teng MS; Si Q; Sun J; Westra WH; Zakowski MF; Szporn AH
    Diagn Cytopathol; 2023 Jan; 51(1):E14-E20. PubMed ID: 36056712
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Advantages and clinical significance of enhanced CT combined with BRAF V600E gene detection in the diagnosis of papillary thyroid carcinoma.
    Zhang J; Zhang J; Han J
    Med Eng Phys; 2022 Dec; 110():103862. PubMed ID: 35933302
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Spindle cell variant of follicular thyroid carcinoma: An extremely unusual case and review of the literature.
    Pusztaszeri MP; Florianova L; Payne R; Baloch ZW
    Diagn Cytopathol; 2022 Nov; 50(11):E333-E338. PubMed ID: 35866458
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Brain metastasis from calcitonin-negative medullary thyroid carcinoma.
    Baptista PF; Fonseca LCM; Carvalho AFC; Silva SNVD; Freitas CRO
    Ann Endocrinol (Paris); 2022 Aug; 83(4):258-260. PubMed ID: 35537523
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Medullary thyroid carcinoma diagnosed with liquid-based cytology and immunocytochemistry.
    Nikas IP; Kazamias G; Vrontaki M; Rapti AS; Mastorakis E
    J Immunoassay Immunochem; 2022 Sep; 43(5):502-515. PubMed ID: 35475413
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. "Incidentally discovered medullary thyroid carcinoma in the post-operative Graves' patient - A case report".
    Akin R; Gilley D; Tassone P
    Am J Otolaryngol; 2022; 43(3):103450. PubMed ID: 35429846
    [TBL] [Abstract] [Full Text] [Related]  

  • 19.
    Pajak C; Cadili L; Nabata K; Wiseman SM
    Am J Surg; 2022 Aug; 224(2):670-675. PubMed ID: 35382933
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis.
    Zhang S; Chen J; Zhang R; Xu L; Wang Y; Yuan Z; Hou X; Feng J
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1063-1077. PubMed ID: 35249158
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.